» Articles » PMID: 29992068

Pregnancy Complications in A-Thalassemia (Hemoglobinopathy H): A Case Study

Overview
Publisher Wiley
Date 2018 Jul 12
PMID 29992068
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Thalassemia intermedia (TI) is a clinical definition which represents a wide spectrum of thalassemia genotypes but mainly includes patients who do not require or only occasionally require transfusion. An uncommon case of a 32-year-old Greek woman, para 1, at the 22nd week + day 3 of gestation with thalassemia intermedia (she was splenectomized), where her pregnancy was complicated with portal vein thrombosis, splenic thrombosis, and partial HELLP, is described. This is a generally uncommon event in thalassemia intermedia. She had no transfusion as her hematologist consulted and she took anticoagulation therapy. Thus, we present for the first time in the literature a case of HbH a-thalassemia pregnant woman whose pregnancy was complicated with portal vein thrombosis, splenic vein thrombosis, and partial HELLP; she was treated with anticoagulation therapy and she had a successful outcome.

Citing Articles

Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice.

Pinto V, Cima R, Di Maggio R, Alga M, Gigante A, Longo F J Clin Med. 2025; 14(3).

PMID: 39941620 PMC: 11818879. DOI: 10.3390/jcm14030948.


Pregnancy in Thalassemia.

Origa R, Comitini F Mediterr J Hematol Infect Dis. 2019; 11(1):e2019019.

PMID: 30858957 PMC: 6402552. DOI: 10.4084/MJHID.2019.019.

References
1.
Levy A, Fraser D, Katz M, Mazor M, Sheiner E . Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2005; 122(2):182-6. DOI: 10.1016/j.ejogrb.2005.02.015. View

2.
Cappellini M, Musallam K, Poggiali E, Taher A . Hypercoagulability in non-transfusion-dependent thalassemia. Blood Rev. 2012; 26 Suppl 1:S20-3. DOI: 10.1016/S0268-960X(12)70007-3. View

3.
Moratelli S, De Sanctis V, Gemmati D, Serino M, Mari R, Gamberini M . Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab. 1999; 11 Suppl 3:915-21. View

4.
Vichinsky E . Clinical manifestations of α-thalassemia. Cold Spring Harb Perspect Med. 2013; 3(5):a011742. PMC: 3633183. DOI: 10.1101/cshperspect.a011742. View

5.
Crary S, Buchanan G . Vascular complications after splenectomy for hematologic disorders. Blood. 2009; 114(14):2861-8. PMC: 2756197. DOI: 10.1182/blood-2009-04-210112. View